Melanotan I (Afamelanotide) Product Brief

Ready-to-Sell Research Product Sheet

1. Compound Overview

Melanotan I, also known as Afamelanotide, is a synthetic analog of the naturally occurring alpha‑melanocyte‑stimulating hormone (α‑MSH).
It has been studied for its role in stimulating melanocortin receptors involved in skin pigmentation and photoprotection pathways.

Melanotan I has attracted research interest in dermatological studies related to pigmentation, UV response, and skin protective signaling mechanisms.

2. Mechanism of Interest

Melanotan I is studied for several biological mechanisms:

• Activation of melanocortin receptors (primarily MC1R)
  • Stimulation of melanin production in melanocytes
  • Potential enhancement of skin pigmentation pathways
  • Possible photoprotective signaling against UV exposure
  • Influence on melanocyte cellular activity

3. Research Areas Being Explored

• Skin pigmentation and melanogenesis research
  • UV response and photoprotection studies
  • Dermatological signaling pathways
  • Melanocyte biology research
  • Skin protective mechanisms

4. Suggested Research Vial Sizes

• 5 mg lyophilized vial
  • 10 mg lyophilized vial
  • 20 mg research vial
  • 50 mg laboratory vial

5. Example Reconstitution Chart

Example mixing protocols commonly used in research contexts:

5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL concentration

10 mg vial + 2 mL bacteriostatic water = 5 mg/mL concentration

20 mg vial + 4 mL bacteriostatic water = 5 mg/mL concentration

These concentrations allow accurate measurement using insulin syringes for laboratory research settings.

6. Label Information for Vials

• Compound name: Melanotan I (Afamelanotide)
  • Total amount per vial (mg)
  • Lot / batch number
  • Manufacturing date
  • Storage instructions (2–8°C recommended)
  • Research use only disclaimer

7. Market Positioning

Melanotan I is commonly positioned in the dermatology and pigmentation research peptide category.

It is frequently associated with research exploring:

• Melanin production pathways
  • Skin pigmentation signaling
  • Photoprotection models
  • Dermatological peptide research

8. Example Research Stack Categories

• Melanotan I + Melanotan II
  • Melanotan I + GHK-Cu
  • Melanotan I + KPV
  • Melanotan I + dermatological peptide stacks

9. Safety and Regulatory Notes

Melanotan I is not approved by the FDA for general cosmetic or medical use outside of specific clinical contexts and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.